Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice

被引:85
|
作者
Persson, L
Borén, J
Robertson, AKL
Wallenius, V
Hansson, GK
Pekna, M
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab Cardiovasc Res, S-40530 Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Res Ctr Endocrinol & Metab, S-40530 Gothenburg, Sweden
[4] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
关键词
atherosclerosis; complement; C3; factor B; hyperlipidemia;
D O I
10.1161/01.ATV.0000127302.24266.40
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - To investigate the effect of complement deficiency on atherogenesis and lipidemia, we used mice deficient in the third complement component (C3-/-) or factor B (FB-/-). Methods and Results - Complement-deficient mice were crossed with mice deficient in both apolipoprotein E and the low-density lipoprotein receptor (Apoe-/- LDLR-/-). The percent lesion area in the aorta at 16 weeks, determined by en face analysis, was 84% higher in C3-/- mice than in controls (11.8% +/- 0.4% versus 6.4% +/- 0.8%, mean +/- SEM, P < 0.00005). The C3-/- mice also had 58% higher serum triglyceride levels (P < 0.05) and a more proatherogenic lipoprotein profile, with significantly more low-density lipoprotein cholesterol and very-low-density lipoprotein triglycerides than control mice. The C3-/- mice weighed 13% less (P < 0.01) and had a lower body fat content (3.5% +/- 1.0% versus 13.1% +/- 3.0%, P < 0.01). There were no differences between FB-/- mice and controls. Conclusions - Complement activation by the classical or lectin pathway exerts atheroprotective effects, possibly through the regulation of lipid metabolism.
引用
收藏
页码:1062 / 1067
页数:6
相关论文
共 50 条
  • [31] Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
    Witting, PK
    Pettersson, K
    Östlund-Lindqvist, AM
    Westerlund, C
    Eriksson, AW
    Stocker, R
    FASEB JOURNAL, 1999, 13 (06): : 667 - 675
  • [32] Angiotensin-Converting Enzyme 2 Deficiency in Whole Body or Bone Marrow-Derived Cells Increases Atherosclerosis in Low-Density Lipoprotein Receptor-/- Mice
    Thatcher, Sean E.
    Zhang, Xuan
    Howatt, Deborah A.
    Lu, Hong
    Gurley, Susan B.
    Daugherty, Alan
    Cassis, Lisa A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (04) : 758 - U87
  • [33] Gene transfers of vascular endothelial growth factor-a, vascular endothelial growth factor-b, vascular endothelial growth factor-c, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice
    Leppänen, P
    Koota, S
    Kholová, I
    Koponen, J
    Fieber, C
    Eriksson, U
    Alitalo, K
    Ylä-Herttuala, S
    CIRCULATION, 2005, 112 (09) : 1347 - 1352
  • [34] Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
    Santo, SMSE
    Pires, NMM
    Boesten, LSM
    Gerritsen, G
    Bovenschen, N
    van Dijk, KW
    Jukema, JW
    Princen, HMG
    Bensadoun, A
    Li, WP
    Herz, J
    Havekes, LM
    van Vlijmen, BJM
    BLOOD, 2004, 103 (10) : 3777 - 3782
  • [35] Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice
    Schepers, A.
    de Vries, M. R.
    van Leuven, C. J.
    Grimbergen, J. M.
    Holers, V. M.
    Daha, M. R.
    van Bockel, J. H.
    Quax, P. H. A.
    CIRCULATION, 2006, 114 (25) : 2831 - 2838
  • [36] Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
    Santo, SME
    Pires, NM
    Gerritsen, G
    Bovenschen, N
    van Dijk, KW
    Princen, HM
    Bensadoun, A
    Herz, J
    Havekes, LM
    van Vlijmen, BJ
    CIRCULATION, 2003, 108 (17) : 257 - 258
  • [37] Conditional knockout of macrophage PPARγ increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice
    Babaev, VR
    Yancey, PG
    Ryzhov, SV
    Kon, V
    Breyer, MD
    Magnuson, MA
    Fazio, S
    Linton, MF
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) : 1647 - 1653
  • [38] Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor-/- Mice
    Bietrix, Florence
    Lombardo, Elisa
    van Roomen, Cindy P. A. A.
    Ottenhoff, Roelof
    Vos, Mariska
    Rensen, Patrick C. N.
    Verhoeven, Arthur J.
    Aerts, Johannes M.
    Groen, Albert K.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (05) : 931 - U108
  • [39] Liver-specific inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice
    Bell, Thomas A., III
    Brown, J. Mark
    Graham, Mark J.
    Lemonidis, Kristina A.
    Crooke, Rosanne M.
    Rudel, Lawrence L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) : 1814 - 1820
  • [40] Salvianolic Acid B Reduces Low-density Lipoprotein Cholesterol and Inhibits Inflammation in Apolipoprotein E-deficient Mice
    Li, Xiaoyan
    Zhang, Xiaona
    Du, Yu
    Lu, Ying
    Xue, Jiaojie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C46 - C47